YSYinhong Song

Yinhong Song

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yinhong Song has a total of 76 co-authors. Here are the top co-authors by number of shared publications:

  • Yongqin Zhou

    Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy China Three Gorges University Yichang China

    4 shared publications
  • Lihong Cui

    College of Basic Medical Science, Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, Yichang Key Laboratory of Infection and Inflammation China Three Gorges University Yichang Hubei China

    3 shared publications
  • Jingyi Zhang

    China Three Gorges University

    2 shared publications
  • Lanlan Yin

    China Three Gorges University

    2 shared publications
  • Lanqi Shang

    Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, People’s Republic of China

    2 shared publications
  • Mengting Lun

    Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, People’s Republic of China

    2 shared publications

Latest Publications

  • Immunomodulatory Effects of Extracts and Active Biomolecules of Morinda officinalis How: A Review

    by Xianyi Lu, Lihong Cui, Jie Luo, Mingyu Du, Yuxian Ren, Xinzhi Li, Yinhong Song

    Introduction/Objective: Global population aging and the rising burden of immunosenescencerelated disorders have created an urgent need for safe, low-toxicity immunomodulators suitable for middleaged and elderly populations. Morinda officinalis How (MO, called “Ba-Ji-Tian” in China), a traditional Chinese kidney-tonifying herb, has shown promising immunomodulatory activity. This review aims to integrate current knowledge on the multidimensional immunomodulatory functions and regulatory networks of MO extracts and their major active biomolecules and summarize their mechanistic contributions in immune-related diseases. Methods: Peer-reviewed literature published over the past decade was comprehensively searched and systematically appraised to evaluate the in vitro and in vivo immunomodulatory effects of MO extracts and their major active constituents, including MO polysaccharides, oligosaccharides, iridoid glycosides, anthraquinones, and sterols. Results: Accumulating evidence indicates that MO exerts bidirectional immunoregulation by modulating cytokine secretion, promoting the proliferation and activation of immune cells including lymphocytes and macrophages, and increasing immune organ indices. Its representative compounds, such as monotropein, rubiadin, physcion, daucosterol, and stigmasterol, contribute to these effects and help alleviate aging-related chronic inflammatory diseases. Discussion: MO extracts and active biomolecules exhibit marked immunomodulatory properties. However, these findings vary across experimental models and doses, and the molecular mechanism remains incompletely defined. Standardized extracts and mechanism-oriented studies are therefore needed to support translational development. Conclusion: MO and its active biomolecules represent promising, mildly acting immunomodulators with considerable potential for clinical application in aging-related immune dysfunction.

  • Fabrication of Protein A–Functionalized Silica‐Encapsulated Carbon Dot Bioconjugates for Cellular Fluorescence Imaging

    by Yuheng Wang, Lihong Cui, Wenxin Yao, Changwen Zhu, Yang Li, Li Li, Yongqin Zhou, Jiaxuan Han, Chenyun Liu, Nuonuo Zhang, et al.

    Fluorescent probes are widely employed in biofluorescence analysis and biomedical imaging. In this study, uniform spherical silica‐encapsulated silicon‐nitrogen co‐doped carbon dots (Si‐MPD‐CDs@SiO 2 ) with a particle size of 24 ± 15 nm were prepared via a modified Stöber method. The nanocomposites were further carboxylated and covalently conjugated with Protein A to construct Si‐MPD‐CDs@SiO 2 @PA bioconjugates. The resulting nanoprobe was successfully applied for specific immunofluorescence labeling and imaging of immortalized mouse thymic epithelial cells (iTECs). Compared with commercial fluorescent secondary antibodies, Si‐MPD‐CDs@SiO 2 @PA exhibit multiple superiorities including low cost, facile preparation and purification, favorable surface modifiability, strong fluorescence emission, and high photostability. These results indicate that Si‐MPD‐CDs@SiO 2 @PA can serve as a promising fluorescent nanoprobe for targeted cellular imaging and related biomedical applications.

  • Open Access

    GW9508 ‐Induced Activation of GPR40 in Thymic Epithelial Cells: A Therapeutic Strategy to Delay Thymic Aging

    by Qingqing Li, Ping Zhu, Lihong Cui, Fenghua Luo, Yongqin Zhou, Yuanyuan Hu, Chunyan Luo, Shanshan Han, Xie Ding, Maoxi Yao, et al.

    Age‐associated thymic involution leads to a reduction of T‐cell production, which constitutes a primary factor in immunosenescence, thereby increasing vulnerability to cancer, infections, and autoimmune disorders. Thymic epithelial cells (TECs), essential for T‐cell development, exhibit progressive senescence with aging. The development of strategies to mitigate TECs senescence and delay thymic degeneration has emerged as a significant research focus. Here, aged C57BL/6J mice and immortalized thymic epithelial cells (iTECs) were hired. The marked reduction of GPR40 expression was observed in TECs from aged mice and in senescent iTECs induced by doxorubicin in vitro. Administration of the GPR40 agonist GW9508, antagonist GW1100, or their combination to aged mice or senescent iTECs demonstrated that GPR40 activation effectively restored thymic function in aged mice. Mechanistically, GW9508 targeted GPR40 to elevate intracellular calcium ion levels, thereby activating the AMPK signaling pathway and inhibiting the hyperactivation of the ERK1/2‐MAPK pathway in senescent cells, ultimately enhancing the activity of aged iTECs. Collectively, these findings suggest that the exogenous activation of GPR40 by GW9508 may represent a viable strategy to alleviate thymic senescence and enhance immune function in aged individuals.

  • Open Access

    A Comprehensive Review of Hedyotis Diffusa Willd–Scutellaria Barbata D. Don Herb Pair in Anti- Hepatocellular Carcinoma Effects and Their Combinatorial Effects and Mechanisms

    by Ya Xu, Weijia Xiang, Wanyi Zhu, Lanqi Shang, Mengting Lun, Songyan Qu, Yizhen Yin, Changrong Chen, Honggang Yuan, Yinhong Song

    Hepatocellular carcinoma (HCC) is among the most prevalent malignancies of the digestive system, with a global rising incidence. Hedyotis diffusa Willd and Scutellaria barbata D. Don are classic herb pair in traditional Chinese medicine (TCM) of clearing heat and detoxifying, and is widely applied in the treatment of HCC. Although existing research has confirmed their efficacy against HCC through modulation of apoptosis, proliferation, angiogenesis, and immune responses, it is noteworthy that the combined or newly generated components after the compatibility of the two herbs exhibit even more pronounced therapeutic effects. In order to verify the pharmacological activity of the combination of Hedyotis diffusa Willd and Scutellaria barbata D. Don, it is necessary to try more in vitro and in vivo models. This review synthesizes current evidence on their TCM compatibility principles, pharmacological actions, and related signaling pathways of this herb pair, providing a rigorous theoretical foundation to guide rational clinical application and further translational research on the compatibility mechanism of the Hedyotis diffusa Willd–Scutellaria barbata D. Don herb pair in the treatment of HCC.


  • Open Access

    Decoding cellular crosstalk to inhibit angiogenesis in rheumatoid arthritis: Integrated approaches for targeted intervention and vascular imaging

    by Chengwei Zhang, Shuze Li, Yinhong Song, Xiang Yu

    Rheumatoid arthritis (RA) is a chronic autoimmune disease pathologically defined by the formation of pannus, a highly vascularized tissue with pronounced proliferative, invasive, and destructive properties. With the molecular mechanisms of angiogenesis becoming increasingly elucidated, targeted interventions are now being developed to disrupt the pro-angiogenic cellular network within the pannus, which is orchestrated by activated endothelial cells, invasive fibroblasts, and infiltrating immune cells. From the perspective of early detection, sensitive noninvasive imaging techniques, including photoacoustic, ultrasound, and nuclear imaging, enable visualization of angiogenesis in RA joints, providing a critical window for timely diagnosis and antiangiogenic treatment. This review synthesizes recent advances in RA angiogenesis research, particularly focusing on molecular mechanisms, novel targeted therapeutic strategies, and advanced imaging techniques for in vivo assessment. Collectively, these developments highlight the paradigm of image-guided antiangiogenic theranostics, which integrates real-time visualization of neovascularization with nanomaterial-based targeted therapeutic intervention to offer a refined approach for early RA management.

  • Open Access

    Recent Advances in Host Immune Mechanisms Against Listeria monocytogenes Infection

    by Lanqi Shang, Weijia Xiang, Mengting Lun, Songyan Qu, Yizhen Yin, Ya Xu, Yongqin Zhou, Ping Zhu, Yinhong Song

    Listeria monocytogenes (Lm) is a foodborne Gram-positive pathogenic bacterium that primarily causes clinical manifestations such as sepsis, meningitis, and monocytosis. The main susceptible populations include newborns, pregnant women, adults over 40 years old, and immunocompromised individuals. Currently, antibiotic therapy remains the primary clinical treatment, but in recent years the issue of antibiotic resistance has become increasingly prominent. This review summarizes recent advances in host immune mechanisms against Lm infection, focusing on: (1) the defensive roles of host barrier systems (intestinal, blood-brain, and placental barriers); (2) innate immune responses, including pathogen recognition via TLRs/NLRs signaling pathways, macrophage phagocytosis, and NK cell immune surveillance; and (3) adaptive immunity, particularly CD4+/CD8+ T cell-mediated specific immune responses and the long-term protective effects of memory T cells. By systematically elucidating the molecular mechanisms of these immune processes, this review aims to provide novel therapeutic strategies through enhancement of host immune functions for clinical management of Lm infection.


  • 4, 9-dihydroxy-α-lapachone as a potent antiproliferation agent for triple-negative breast cancer via ferroptosis

    by Zhong He, Hui Long, Hongyue Ma, Wanrong Ran, Yinhong Song, Wenjuan Shang, Junhui Wang, Ye Qin, Zhangshuang Deng


  • Open Access

    Acanthopanax senticosus polysaccharides attenuates Klebsiella infection in immunocompromised mice by modulating immunity

    by Zihan Liang, Yiyao Wang, Jingyi Zhang, Yixiang Lai, Lanlan Yin, Zhe Chen, Lun Li, Yongqin Zhou, Yaguang Deng, Ping Zhu, et al.

    Radiotherapy and chemotherapy compromise individuals’ immunity clinically, resulting in increased opportunistic infections. In this study, the cyclophosphamide-induced immunocompromised C57BL/6J mouse with Klebsiella infection was hired to analyze the effect of the active components of Acanthopanax senticosus on anti-infection for immunocompromised individuals. As a result, Acanthopanax senticosus polysaccharide (ASPS) was selected with the best effect. For immunocompromised C57BL/6J mouse, ASPS increased its indices of thymus and spleen, reducing the bacteria load in lung and protecting the function of liver. Meanwhile, ASPS obviously boosted the total number of thymocytes and the number of CD4+ T cells in spleen, promoting the proportions of CD4+ TCM and TEM cells, while decreasing that of CD4+ TEMRA cells in in peripheral blood. Moreover, ASPS enhanced the number of NF-κB+, CD192+ Mφ and NF-κB+ neutrophils in the abdomen and strengthened their antibacterial function, however, reduced the number of NF-κB+ Mφ and neutrophils in the spleen reducing inflammation. It is also observed by immunofluorescence that the NF-κB expression of peritoneal Mφ increased evidently after the mice were treated with ASPS. In conclusion, ASPS has an obvious effect against infection for immunocompromised mice by promoting immunity recovery.

  • Open Access

    Targeting LSD1 in tumor immunotherapy: rationale, challenges and potential

    by Lei Bao, Ping Zhu, Yuan Mou, Yinhong Song, Ye Qin

    Lysine-specific demethylase 1 (LSD1) is an enzyme that removes lysine methylation marks from nucleosome histone tails and plays an important role in cancer initiation, progression, metastasis, and recurrence. Recent research shows that LSD1 regulates tumor cells and immune cells through multiple upstream and downstream pathways, enabling tumor cells to adapt to the tumor microenvironment (TME). As a potential anti-tumor treatment strategy, immunotherapy has developed rapidly in the past few years. However, most patients have a low response rate to available immune checkpoint inhibitors (ICIs), including anti-PD-(L)1 therapy and CAR-T cell therapy, due to a broad array of immunosuppressive mechanisms. Notably, inhibition of LSD1 turns “cold tumors” into “hot tumors” and subsequently enhances tumor cell sensitivity to ICIs. This review focuses on recent advances in LSD1 and tumor immunity and discusses a potential therapeutic strategy for combining LSD1 inhibition with immunotherapy.